Advanced Biomed ADVB
NASDAQ ADVB
$9.50 +0.26 (+2.81%)
As of: Aug 27, 2026 · 3:59 PM EDT

Advanced Biomed (ADVB) Other financing activities (2024 - 2025)

Advanced Biomed (ADVB) posted Other financing activities of -$5.9 million for Q4 2025, down 190.22% sequentially from $6.6 million in Q3 2025, and down 35127.64% YoY from N/an in Q4 2024.

Advanced Biomed (ADVB) Other financing activities (2024 - 2025) Analysis & Trends

Advanced Biomed has reported Other financing activities for 2 years, with the latest figure at -$5.9 million in Q4 2025.

  • Quarterly Other financing activities fell 35127.64% year-over-year to -$5.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $5.8 million (changed N/A YoY) and the FY2025 annual result came in at $5.5 million, up 6533.02% from the prior year.
  • Other financing activities retreated to -$5.9 million in Q4 2025 per ADVB's latest filing, from $6.6 million in the prior quarter.
  • Over five years, Other financing activities peaked at $6.6 million in Q3 2025 and troughed at -$5.9 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Advanced Biomed 12.28 Mn 12.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.92 Mn
Dec 31, 2025 -5.92 Mn
Sep 30, 2025 6.56 Mn
Sep 30, 2025 6.56 Mn
Jun 30, 2025 5.16 Mn
Jun 30, 2025 5.16 Mn
Mar 31, 2025 4,720.00
Mar 31, 2025 4,720.00
Dec 31, 2024 346,759.00
Dec 31, 2024 346,759.00
Sep 30, 2024 -16,800.00
Sep 30, 2024 -16,800.00